JENNIFER REID: Open Payments
NPI 1003583246 · FLORENCE, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$420 in 24 payments from 13 companies in 2025. Trend: 2023 $678 · 2024 $443 · 2025 $420
Food & beverage: $420
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 4 | $75 |
| AstraZeneca Pharmaceuticals LP | 4 | $69 |
| Novo Nordisk Inc | 3 | $63 |
| GlaxoSmithKline, LLC. | 2 | $38 |
| Exact Sciences Corporation | 2 | $35 |
| Abbott Laboratories | 2 | $32 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $18 |
| Esperion Therapeutics, Inc. | 1 | $17 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $15 |
| Phathom Pharmaceuticals, Inc. | 1 | $15 |
Products named: VRAYLAR, Wegovy, AIRSUPRA, Cologuard Collection Kit, FREESTYLE LIBRE 3, FARXIGA, SHINGRIX, CAPLYTA.
Industry payments across SC — which companies pay providers there.
